163 related articles for article (PubMed ID: 27039176)
1. Early mortality in lung cancer: French prospective multicentre observational study.
Grivaux M; Debieuvre D; Herman D; Lemonnier C; Marcos JM; Crequit J; Vuillermoz-Blas S; Barre P; Saillour M; Martin F
BMC Pulm Med; 2016 Apr; 16():45. PubMed ID: 27039176
[TBL] [Abstract][Full Text] [Related]
2. The new face of non-small-cell lung cancer in men: Results of two French prospective epidemiological studies conducted 10 years apart.
Debieuvre D; Oster JP; Riou R; Berruchon J; Levy A; Mathieu JP; Dumont P; Leroy-Terquem E; Tizon-Couetil V; Martin F; Grivaux M
Lung Cancer; 2016 Jan; 91():1-6. PubMed ID: 26711927
[TBL] [Abstract][Full Text] [Related]
3. [One-year survival improvement in lung cancer in France. Results of the prospective real life studies KBP-2000-CPHG and KBP-2010-CPHG].
Grivaux M; Duvert B; Ferrer-Lopez P; Hominal S; Goarant E; Brichet-Martin A; Romand P; Fournier E; Asselain B; Debieuvre D
Rev Pneumol Clin; 2016 May; 72(3):163-70. PubMed ID: 27113617
[TBL] [Abstract][Full Text] [Related]
4. Risk Factors for Lung Cancer Mortality in a Referral Center.
Jamaati H; Baghaei P; Sharifianfard M; Emami H; Najmi K; Seifi S; Salimi B; Pourabdollah M; Kiani A; Hashemian M; Khosravi A
Asian Pac J Cancer Prev; 2016; 17(6):2877-81. PubMed ID: 27356706
[TBL] [Abstract][Full Text] [Related]
5. Japanese Lung Cancer Registry Study: first prospective enrollment of a large number of surgical and nonsurgical cases in 2002.
Sawabata N; Asamura H; Goya T; Mori M; Nakanishi Y; Eguchi K; Koshiishi Y; Okumura M; Miyaoka E; Fujii Y;
J Thorac Oncol; 2010 Sep; 5(9):1369-75. PubMed ID: 20683209
[TBL] [Abstract][Full Text] [Related]
6. [Cohort KBP-2000-CPHG: Evaluation of factors influencing survival in lung cancer].
Blanchon F; Grivaux M; Zureik M; Marsal L; Asselain B; Lebas FX; Orlando JP; Steenhouwer F; Benichou-Flurin M; Coëtmeur D; Collon T; David P; Delclaux B; Piquet J
Rev Mal Respir; 2006 Apr; 23(2 Pt 1):165-71. PubMed ID: 16788443
[TBL] [Abstract][Full Text] [Related]
7. Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC.
Kawaguchi T; Takada M; Kubo A; Matsumura A; Fukai S; Tamura A; Saito R; Maruyama Y; Kawahara M; Ignatius Ou SH
J Thorac Oncol; 2010 May; 5(5):620-30. PubMed ID: 20354456
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in lung cancer in a defined geographical area over two decades with a special emphasis on gender.
Svensson G; Ewers SB; Ohlsson O; Olsson H
Clin Respir J; 2013 Jan; 7(1):91-100. PubMed ID: 22380488
[TBL] [Abstract][Full Text] [Related]
9. Evidence of slight improvement in five-year survival in non-small-cell lung cancer over the last 10 years: Results of the French KBP-CPHG real-world studies.
Debieuvre D; Locher C; Asselain B; Dayen C; Molinier O; Falchero L; Dujon C; Delclaux B; Grivaux M
Bull Cancer; 2019 Apr; 106(4):283-292. PubMed ID: 30803715
[TBL] [Abstract][Full Text] [Related]
10. Clinical features of large cell neuroendocrine carcinoma: a population-based overview.
Derks JL; Hendriks LE; Buikhuisen WA; Groen HJ; Thunnissen E; van Suylen RJ; Houben R; Damhuis RA; Speel EJ; Dingemans AM
Eur Respir J; 2016 Feb; 47(2):615-24. PubMed ID: 26541538
[TBL] [Abstract][Full Text] [Related]
11. Five-year survival and prognostic factors according to histology in 6101 non-small-cell lung cancer patients.
Molinier O; Goupil F; Debieuvre D; Auliac JB; Jeandeau S; Lacroix S; Martin F; Grivaux M
Respir Med Res; 2020 Mar; 77():46-54. PubMed ID: 32036284
[TBL] [Abstract][Full Text] [Related]
12. Phase 2 study of frontline bortezomib in patients with advanced non-small cell lung cancer.
Besse B; Planchard D; Veillard AS; Taillade L; Khayat D; Ducourtieux M; Pignon JP; Lumbroso J; Lafontaine C; Mathiot C; Soria JC
Lung Cancer; 2012 Apr; 76(1):78-83. PubMed ID: 22186627
[TBL] [Abstract][Full Text] [Related]
13. Multiple independent primary cancers do not adversely affect survival of the lung cancer patient.
Aguiló R; Macià F; Porta M; Casamitjana M; Minguella J; Novoa AM
Eur J Cardiothorac Surg; 2008 Nov; 34(5):1075-80. PubMed ID: 18824369
[TBL] [Abstract][Full Text] [Related]
14. Stage III non-small-cell lung cancer: population-based patterns of treatment in British Columbia, Canada.
Vinod SK; Wai E; Alexander C; Tyldesley S; Murray N
J Thorac Oncol; 2012 Jul; 7(7):1155-63. PubMed ID: 22617240
[TBL] [Abstract][Full Text] [Related]
15. Lymphovascular invasion in non-small-cell lung cancer: implications for staging and adjuvant therapy.
Higgins KA; Chino JP; Ready N; D'Amico TA; Berry MF; Sporn T; Boyd J; Kelsey CR
J Thorac Oncol; 2012 Jul; 7(7):1141-7. PubMed ID: 22617241
[TBL] [Abstract][Full Text] [Related]
16. Clinical and pathological characteristics, outcome and mutational profiles regarding non-small-cell lung cancer related to wood-smoke exposure.
Arrieta O; Campos-Parra AD; Zuloaga C; Avilés A; Sánchez-Reyes R; Manríquez ME; Covián-Molina E; Martínez-Barrera L; Meneses A; Cardona A; Borbolla-Escoboza JR
J Thorac Oncol; 2012 Aug; 7(8):1228-34. PubMed ID: 22659961
[TBL] [Abstract][Full Text] [Related]
17. Histology and smoking status predict survival of patients with advanced non-small-cell lung cancer. Results of West Japan Oncology Group (WJOG) Study 3906L.
Kogure Y; Ando M; Saka H; Chiba Y; Yamamoto N; Asami K; Hirashima T; Seto T; Nagase S; Otsuka K; Yanagihara K; Takeda K; Okamoto I; Aoki T; Takayama K; Yamasaki M; Kudoh S; Katakami N; Miyazaki M; Nakagawa K
J Thorac Oncol; 2013 Jun; 8(6):753-8. PubMed ID: 23575412
[TBL] [Abstract][Full Text] [Related]
18. The Frequency and Prognostic Impact of Pathological Microscopic Vascular Invasion According to Tumor Size in Non-Small Cell Lung Cancer.
Shimada Y; Saji H; Kato Y; Kudo Y; Maeda J; Yoshida K; Hagiwara M; Matsubayashi J; Kakihana M; Kajiwara N; Ohira T; Ikeda N
Chest; 2016 Mar; 149(3):775-85. PubMed ID: 26379115
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of patients with lung cancer in the city of Manaus, Brazil.
Westphal FL; Lima LC; Andrade EO; Lima Netto JC; Silva AS; Carvalho BC
J Bras Pneumol; 2009 Feb; 35(2):157-63. PubMed ID: 19287919
[TBL] [Abstract][Full Text] [Related]
20. Prediagnostic nonsteroidal anti-inflammatory drug use and lung cancer survival in the VITAL study.
Brasky TM; Baik CS; Slatore CG; Alvarado M; White E
J Thorac Oncol; 2012 Oct; 7(10):1503-12. PubMed ID: 22982651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
